about
Bisphosphonate therapy for children and adolescents with secondary osteoporosisA novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factorHomozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defectsMutations in SERPINF1 cause osteogenesis imperfecta type VICRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfectaHip Dysplasia in Children With Osteogenesis Imperfecta: Association With Collagen Type I C-Propeptide MutationsPediatric reference Raman data for material characteristics of iliac trabecular bone.Modeling of cross-sectional bone size, mass and geometry at the proximal radius: a study of normal bone development using peripheral quantitative computed tomography.Pediatric data for dual X-ray absorptiometric measures of normal lumbar bone mineral density in children under 5 years of age using the lunar prodigy densitometer.Normative data for iliac bone histomorphometry in growing children.The 'muscle-bone unit' during the pubertal growth spurt.Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta.Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults.Higher BMC and areal BMD in children and grandchildren of individuals with hip or knee replacementHigh incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapySkeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndromeAlendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study.Reproducibility of jumping mechanography in healthy children and adults.Gait analysis using a force-measuring gangway: intrasession repeatability in healthy adults.Hyperuricemia cosegregating with osteogenesis imperfecta is associated with a mutation in GPATCH8.Muscle-bone characteristics in children with Prader-Willi syndrome.Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone.Abnormalities in muscle density and muscle function in hypophosphatemic rickets.Muscle anatomy and dynamic muscle function in osteogenesis imperfecta type I.Validity of an accelerometer as a vertical ground reaction force measuring device in healthy children and adolescents and in children and adolescents with osteogenesis imperfecta type I.The functional muscle-bone unit in patients with osteogenesis imperfecta type I.Physical activity in youth with osteogenesis imperfecta type I.From pediatric to adult care: strategic evaluation of a transition program for patients with osteogenesis imperfecta.Effect of high-dose vitamin D supplementation on bone density in youth with osteogenesis imperfecta: A randomized controlled trial.The impact of severe osteogenesis imperfecta on the lives of young patients and their parents - a qualitative analysisImpact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta.Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis.Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational studyGlucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseasesLoss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.Bone health in children and adolescents: a symposium at the annual meeting of the Pediatric Academic Societies/Lawson Wilkins Pediatric Endocrine Society, May 2003.Involving Families with Osteogenesis Imperfecta in Health Service Research: Joint Development of the OI/ECE Questionnaire.Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic DisordersMetaphyseal dysplasia with maxillary hypoplasia and brachydactyly is caused by a duplication in RUNX2.Medical therapy of children with fibrous dysplasia.
P50
Q24243298-3057CFD8-8D4B-4F0C-B627-8283E183F33AQ24336923-4B636804-41C0-412E-9E7E-69E4DB92AAA9Q24337891-F0F6822B-8E1F-4515-A994-9DCAF867B818Q24629521-159B21C7-4E35-4469-84F9-DCF49A681B4CQ28592442-80DB3ACA-BEF1-411C-A091-29309F34A922Q30488329-130641C3-7634-4F4B-8335-443708D0CC16Q30854490-416AA913-314D-4354-8F09-2B560C8E47EBQ31005039-FBFE6678-8185-4EC9-9FF1-67AC7FD17CB4Q31127914-58108185-DE53-424B-8EEE-A479F49F8627Q31516131-E534CE0F-76E9-4046-B192-0668E35C0CD1Q33202531-3D87AD73-16CF-4E8B-A9C8-A4421635D4FCQ33269240-EE5B118C-68CC-4D95-9CE7-0B905C216BCEQ33415776-6DFB9DF9-7223-4C08-9EA1-EA392C726595Q33522497-9279FF14-5E1A-4A93-8E55-BD6386DCA31DQ33618291-69849D04-D79E-4948-8EB5-E037969480B9Q33911068-265ECCF9-FCCF-4F84-B975-5E3A9123F250Q34024815-A5C60BA6-5E27-45C7-A358-FBDA16DE982CQ34152370-294FA193-61D4-4CE7-87B7-E72D2DB887DAQ34167772-17905698-478A-4D5F-9CCE-18AB7415C2D2Q34186159-E8A784E5-57A5-4FCB-9F33-EA4B81643D44Q34240247-67C180A5-4407-470E-9F49-C26357FEF776Q34269688-313818E5-0130-48D8-BF64-9C49DCBDDFF8Q34277658-CAB4AEE6-2723-4525-AEA3-6ED259E2B512Q34386084-E12D9869-BB4C-44DA-BDB6-7A456C113D18Q34422116-C199515A-6BA9-44BC-B6C2-8AA4AAE8575BQ34477693-B607D44F-183A-428F-84B2-25CE2A7B104DQ34478800-71ACC985-786A-43E8-8494-6E6234DFD435Q34491259-B4DBD23C-2008-4CA6-AB52-2C088B254A68Q34516095-33550E91-4EF3-493E-B8D8-8ADBDBF8C0E3Q35001339-46A51CF3-5343-40B4-B1AB-C3DCC82B84A5Q35094817-226A43F3-4BE0-4C3B-AEEC-D4B0AE96D512Q35672448-BB8157EA-B05C-47DC-B715-B347D61BD7D3Q35695632-C7BBFD90-BFBE-4E95-8817-EBF883097E85Q35695662-BC92F94D-6C9F-454F-B714-5D1EE5394145Q35728669-CB734CB1-ED3A-4998-8074-B3D527A46000Q35825841-D275B5C3-F34A-43C7-AF9C-41BAB978E522Q35901568-E5D35FE4-D6D6-4548-88B1-ED65BC714AB6Q36016387-9AF9F432-700F-4EC1-B70D-2121C4743016Q36595115-5B10B6BA-D07A-41EA-A8CF-1C59594D04E7Q36710132-4C493446-4070-43B6-B4A0-CD233B445666
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Frank Rauch
@ast
Frank Rauch
@en
Frank Rauch
@es
Frank Rauch
@sl
type
label
Frank Rauch
@ast
Frank Rauch
@en
Frank Rauch
@es
Frank Rauch
@sl
prefLabel
Frank Rauch
@ast
Frank Rauch
@en
Frank Rauch
@es
Frank Rauch
@sl
P106
P1153
7005490104
P21
P31
P496
0000-0002-6261-0360